{
    "Trade/Device Name(s)": [
        "Elecsys Anti-CCP Immunoassay",
        "Elecsys PreciControl Anti-CCP"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K081338",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052133"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHX",
        "JJX"
    ],
    "Summary Letter Date": "July 31, 2008",
    "Summary Letter Received Date": "August 4, 2008",
    "Submission Date": "May 9, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.5775"
    ],
    "Regulation Name(s)": [
        "Rheumatoid factor immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG autoantibodies to cyclic citrullinated peptides",
        "Anti-CCP antibody"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010",
        "MODULAR ANALYTICS E170",
        "cobas e 411",
        "cobas e 601"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "IgG-capture immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Anti-CCP Immunoassay and Elecsys PreciControl Anti-CCP for detection of anti-CCP IgG autoantibodies aiding rheumatoid arthritis diagnosis",
    "Indications for Use Summary": "Aids in diagnosis of rheumatoid arthritis by semi-quantitative determination of human IgG autoantibodies to cyclic citrullinated peptides in serum and plasma using electrochemiluminescence immunoassay on specified analyzers",
    "fda_folder": "Immunology"
}